Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease - Wikidata - awgldk - TriplyDB

Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease

Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease

http://www.wikidata.org/entity/Q34826133

about

Theoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's Disease Liver growth factor as a tissue regenerating factor in neurodegenerative diseases Neuroprotective role of liver growth factor "LGF" in an experimental model of cerebellar ataxia Proliferative activity of liver growth factor is associated with an improvement of cigarette smoke-induced emphysema in mice.Liver Growth Factor (LGF) Upregulates Frataxin Protein Expression and Reduces Oxidative Stress in Friedreich's Ataxia Transgenic Mice.Liver growth factor treatment reverses emphysema previously established in a cigarette smoke exposure mouse model.

P2860

Q26746174-66A6DDEE-BD38-4D7E-95C2-FA3606A31770 Q26861673-F96CB84B-D136-4986-89FC-0FC762B397CB Q28397547-33D02C5D-B883-44FE-8BEE-B8C027B1CD9F Q35426508-28428B47-43BC-49CA-9AC6-7BB3B5D37830 Q39935809-CD38988E-93B5-4E81-BF55-E257EFACE0D3 Q45282765-66B98686-7BDE-4221-9491-8137DB9E3D06

P2860

Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease

http://www.wikidata.org/entity/Q34826133

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Neuroprotective activity of pe ...... t model of Parkinson's disease

@ast

Neuroprotective activity of pe ...... t model of Parkinson's disease

@en

Neuroprotective activity of pe ...... t model of Parkinson's disease

@nl

type

label

Neuroprotective activity of pe ...... t model of Parkinson's disease

@ast

Neuroprotective activity of pe ...... t model of Parkinson's disease

@en

Neuroprotective activity of pe ...... t model of Parkinson's disease

@nl

prefLabel

Neuroprotective activity of pe ...... t model of Parkinson's disease

@ast

Neuroprotective activity of pe ...... t model of Parkinson's disease

@en

Neuroprotective activity of pe ...... t model of Parkinson's disease

@nl

P1433

Q34826133-E0B9026A-E347-440D-8B84-9DBCA025C238

P1476

Q34826133-EB2C3AF2-6594-4157-8D0B-69D26D44E587

P2093

Q34826133-09E1D0C2-067D-4ACB-A428-28682B70842A

Q34826133-0D0657B1-5689-4413-83CE-CA7705A1C99A

Q34826133-58482229-4E47-45C3-82CD-91FE7A510D8E

Q34826133-7568A7A1-5787-4490-81F8-62295D6AA28C

P2860

Q34826133-0228A3D3-DE04-4FBF-B7D2-4DC8E1CE164C

Q34826133-02FBAC87-30E3-4141-92BD-BEFFB366A36A

Q34826133-0477F0FB-C652-449E-BFD3-EA0180398149

Q34826133-057AB39B-72EF-4C78-81C6-0177881000E1

Q34826133-06FF45A0-3E26-42D4-B8E5-364924574480

Q34826133-0709EB56-3C75-4A47-AA41-D52569235D22

Q34826133-0A77A670-F0DC-445E-9D86-BDDB388A9CC0

Q34826133-10D9649A-7E49-4B51-88F0-723BD8866C59

Q34826133-19E427DA-6CA6-4F52-B73A-14315BBD4507

Q34826133-1A79A015-F4C4-4E22-BA62-CD60E00DB12F

P304

Q34826133-97A4C53D-A496-4158-A711-934757A29702

P31

Q34826133-62056BCF-23B3-421A-B208-DA21C313B7EE

P356

Q34826133-20DEFEAB-AA23-4DEE-AFBF-BE556331C63A

P407

Q34826133-E1D87DF2-88C4-4CCB-85ED-A27959780633

P433

Q34826133-587547DB-D5CA-467A-BAC1-4DD1B07FDA1A

P478

Q34826133-2AFBD1C8-1C42-4417-99D4-08FDE78785A9

P50

Q34826133-00BEFB36-85C1-4722-9FD1-571C486B5495

Q34826133-065A760E-F552-4AE6-93D7-736BA1FEA4CC

Q34826133-7EA6E6C2-C5F1-4E4E-B7C2-8BDA0AD4785D

Q34826133-D2190065-2CDB-4D7A-9FE9-C7B8446A9027

Q34826133-E780D76B-294F-4672-89F2-9FC4B8C86723

P577

Q34826133-403EE924-5E81-4297-AD8A-F34E61CE20A4

P5875

Q34826133-D529E7FC-677F-40EE-8CFB-00834D39A032

P698

Q34826133-80CFF33C-8BC6-422E-8B64-ED535C4A967E

P921

Q34826133-B2DCF80E-65F9-42E5-A93C-4F0CADEF6B4E

P932

Q34826133-A862B9C1-35A1-406C-A05E-B95FAD2201AE

P356

JOURNAL.PONE.0067771

P1433

P1476

Neuroprotective activity of pe ...... t model of Parkinson's disease

@en

P2093

Antonio Sánchez Herranz

http://www.w3.org/2001/XMLSchema#string

Cristina Miranda

http://www.w3.org/2001/XMLSchema#string

Eulalia Bazán

http://www.w3.org/2001/XMLSchema#string

Juan José Díaz-Gil

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroprotection of insulin against oxidative stress-induced apoptosis in cultured retinal neurons: involvement of phosphoinositide 3-kinase/Akt signal pathway

The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury

Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs

The mitogenic activity of the liver growth factor is mediated by tumor necrosis factor alpha in rat liver

Axonal protection by brain-derived neurotrophic factor associated with CREB phosphorylation in tumor necrosis factor-alpha-induced optic nerve degeneration

Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease.

Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.

Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells.

Albumin activates astrocytes and microglia through mitogen-activated protein kinase pathways.

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.

P304

e67771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0067771

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Adriano Jiménez-Escrig

Macarena Rodríguez

Rafael Gonzalo-Gobernado

Lucía Calatrava-Ferreras

P577

2013-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249967419

http://www.w3.org/2001/XMLSchema#string

P698

23861803

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3701531

http://www.w3.org/2001/XMLSchema#string